ArticleMethodsX2026
Comparing the effect of virtual reality and transcranial direct current stimulation on fear of falling, balance, and walking ability in stroke: A randomized controlled trial protocol.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fear of falling is a prevalent and disabling problem after stroke, contributing to reduced activity, impaired balance, and increased fall risk. Recent studies indicate that virtual reality (VR)-based interventions and transcranial direct current stimulation (tDCS) applied during exercise therapy may help reduce fear of falling in individuals with neurological disorders. This single‑center, assessor‑blinded randomized controlled trial aims to compare the effects of VR‑based gait training with tDCS combined with gait training on fear of falling in patients with subacute stroke. Participants will be randomly allocated to either the VR or tDCS group, while all also receive conventional physiotherapy. Outcomes will be assessed at baseline and after ten treatment sessions by a blinded assessor. The primary outcome is fear of falling, measured using the Falls Efficacy Scale‑International (FES‑I). Secondary outcomes include balance, assessed by the Mini‑BESTest and Biodex Balance System, as well as walking ability, assessed by the 10‑Meter Walk Test. It is hypothesized that VR‑based gait training will result in a greater reduction in fear of falling than tDCS combined with gait training.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.